深圳市龙岗区耳鼻咽喉医院依托"港澳药械通"政策,于8月6日成功完成深圳东部首例CI632进口人工耳蜗植入手术 [1]。患者张先生因双耳听力衰退十余年,在曾宪海教授团队治疗下接受手术,术后恢复平稳,预计一个月后可佩戴声音处理器恢复听觉功能 [1]。
该医院已成为龙岗区首家、大湾区唯一具备"港澳药械通"资质的三级公立耳鼻咽喉专科医院 [1]。所植入的CI632人工耳蜗搭载全球最精细手术电极,兼容3.0T核磁共振检查,并采用专属近蜗轴弯电极设计 [1]。
Longgang District ENT Hospital in Shenzhen successfully performed the eastern district's first CI632 imported cochlear implant surgery on August 6, leveraging the "Guangdong-Hong Kong-Macau Medical Device Channel" policy [1]. The patient, Mr. Zhang, who had experienced bilateral hearing loss for over a decade, underwent the procedure under the care of Professor Zeng Xianhai's medical team [1]. Post-operative recovery has proceeded smoothly, with hearing function expected to be restored approximately one month after the patient begins wearing the sound processor [1].
The CI632 cochlear implant device features globally refined surgical electrodes, compatibility with 3.0T magnetic resonance imaging examinations, and a specialized perimodiolar curved electrode design [1]. Longgang District ENT Hospital has become the first hospital in Longgang District and the only three-level public specialist ENT hospital in the Greater Bay Area to hold the qualifications necessary to provide the "Guangdong-Hong Kong-Macau Medical Device Channel" service [1].